OPRM1 and colorectal cancer: Additionally, a further retrospective cohort study [13], examining patients with stage I–III colorectal cancer demonstrated that despite increased expression of Opioid Growth Factor Receptor and mu-opioid receptor (MOR), this did not translate into an association with altered recurrence rates.